|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US5276019A
(en)
|
1987-03-25 |
1994-01-04 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
|
US5264423A
(en)
|
1987-03-25 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibitors for replication of retroviruses and for the expression of oncogene products
|
|
AU655164B2
(en)
|
1989-12-20 |
1994-12-08 |
Antivirals Inc. |
Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
|
|
US5525491A
(en)
|
1991-02-27 |
1996-06-11 |
Creative Biomolecules, Inc. |
Serine-rich peptide linkers
|
|
US5955599A
(en)
|
1995-06-01 |
1999-09-21 |
Hybridon, Inc. |
Process for making oligonucleotides containing o- and s- methylphosphotriester internucleoside linkages
|
|
JP4148662B2
(ja)
|
2000-08-10 |
2008-09-10 |
第一三共株式会社 |
ヌクレオシド及びオリゴヌクレオチド類縁体を含有する核酸試薬及び医薬
|
|
ES2234563T5
(es)
|
1999-02-12 |
2018-01-17 |
Daiichi Sankyo Company, Limited |
Nuevos análogos de nucleósidos y oligonucleótidos
|
|
IL155812A0
(en)
|
2000-12-07 |
2003-12-23 |
Lilly Co Eli |
Glp-1 fusion proteins
|
|
EP2392660A3
(en)
|
2002-11-25 |
2012-03-28 |
Masafumi Matsuo |
ENA Nucleic Acid Drugs Modifying Splicing in mRNA Precursor
|
|
CA2518475C
(en)
|
2003-03-07 |
2014-12-23 |
Alnylam Pharmaceuticals, Inc. |
Irna agents comprising asymmetrical modifications
|
|
EP2933332A1
(en)
|
2004-06-28 |
2015-10-21 |
The University Of Western Australia |
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
|
|
WO2007066627A1
(ja)
|
2005-12-06 |
2007-06-14 |
The University Of Tokyo |
多目的アシル化触媒とその用途
|
|
JP2009536222A
(ja)
|
2006-05-05 |
2009-10-08 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
Ｐｃｓｋ９の発現を調節するための化合物および方法
|
|
CA2666191C
(en)
|
2006-10-09 |
2017-07-11 |
Santaris Pharma A/S |
Rna antagonist compounds for the modulation of pcsk9
|
|
ES2526295T5
(es)
|
2006-10-18 |
2021-05-04 |
Ionis Pharmaceuticals Inc |
Compuestos antisentido
|
|
RU2606627C2
(ru)
|
2007-11-15 |
2017-01-10 |
Серепта Терапьютикс,Инк. |
Способ синтеза морфолиновых олигомеров
|
|
WO2009147368A1
(en)
|
2008-06-04 |
2009-12-10 |
Medical Research Council |
Peptides
|
|
US8084601B2
(en)
|
2008-09-11 |
2011-12-27 |
Royal Holloway And Bedford New College Royal Holloway, University Of London |
Oligomers
|
|
CA2778171C
(en)
|
2009-10-29 |
2017-07-25 |
Osaka University |
Bridged artificial nucleoside and nucleotide
|
|
TWI541024B
(zh)
|
2010-09-01 |
2016-07-11 |
日本新藥股份有限公司 |
反義核酸
|
|
CA3092114A1
(en)
|
2011-05-05 |
2012-11-08 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
|
CN103998458B
(zh)
|
2011-08-30 |
2018-10-09 |
医学研究理事会 |
具有中央疏水域的细胞穿透肽
|
|
JP6112569B2
(ja)
|
2011-12-16 |
2017-04-12 |
国立大学法人 東京医科歯科大学 |
キメラ２重鎖核酸
|
|
CA2861247C
(en)
|
2011-12-28 |
2021-11-16 |
Nippon Shinyaku Co., Ltd. |
Antisense nucleic acids
|
|
TWI616531B
(zh)
|
2012-09-19 |
2018-03-01 |
傑姆維克斯＆凱爾有限公司 |
穿膜胜肽以及包含該胜肽之共軛物及組成物（二）
|
|
KR101707437B1
(ko)
|
2012-09-21 |
2017-02-16 |
고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 |
구아니딘 가교를 갖는 인공 뉴클레오시드 및 올리고뉴클레오티드
|
|
GB201314411D0
(en)
|
2013-08-12 |
2013-09-25 |
Medical Res Council |
Peptide conjugates
|
|
CN106103463B
(zh)
|
2014-02-18 |
2018-11-30 |
国立大学法人大阪大学 |
桥连型核苷和核苷酸
|
|
US20150329609A1
(en)
*
|
2014-03-03 |
2015-11-19 |
Sujata Acharjee |
Chimeric dystrophin proteins to treat dystrophinopathies
|
|
WO2015168172A1
(en)
|
2014-04-28 |
2015-11-05 |
Isis Pharmaceuticals, Inc. |
Linkage modified oligomeric compounds
|
|
MX373052B
(es)
|
2014-06-17 |
2020-05-11 |
Nippon Shinyaku Co Ltd |
Acidos nucleicos antisentido.
|
|
WO2016081600A1
(en)
|
2014-11-18 |
2016-05-26 |
Zata Pharmaceuticals, Inc. |
Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds
|
|
EA039366B1
(ru)
*
|
2015-06-24 |
2022-01-19 |
Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. |
Антитело к рецептору трансферрина человека, проникающее через гематоэнцефалический барьер
|
|
DK3473270T5
(da)
|
2016-06-20 |
2024-09-09 |
Genahead Bio Inc |
Konjugat af antistof-lægemiddel
|
|
MX2020003130A
(es)
*
|
2017-09-22 |
2020-09-25 |
Avidity Biosciences Inc |
Composiciones y metodos de induccion de salto de exon en acidos nucleicos-polipeptidos.
|
|
US11168141B2
(en)
*
|
2018-08-02 |
2021-11-09 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
CA3108282A1
(en)
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
CN113677374A
(zh)
|
2019-04-08 |
2021-11-19 |
国立大学法人东京医科齿科大学 |
肌疾病治疗用药物组合物
|
|
WO2020219820A1
(en)
*
|
2019-04-25 |
2020-10-29 |
Avidity Biosciences, Inc. |
Nucleic acid compositions and methods of multi-exon skipping
|
|
WO2021054370A1
(ja)
|
2019-09-18 |
2021-03-25 |
国立大学法人東京医科歯科大学 |
核酸複合体
|
|
JP7780691B2
(ja)
*
|
2020-01-10 |
2025-12-05 |
ダイン セラピューティクス，インコーポレーテッド |
ジストロフィン異常症を処置するための筋標的化複合体およびそれらの使用
|
|
CA3163608A1
(en)
*
|
2020-01-10 |
2021-07-15 |
Romesh R. Subramanian |
Muscle-targeting complexes and uses thereof
|
|
WO2021167107A1
(ja)
*
|
2020-02-22 |
2021-08-26 |
Ｊｃｒファーマ株式会社 |
ヒトトランスフェリンレセプター結合ペプチド
|